Gilead and Arcellx reported promising data for their CAR-T therapy anito-cel at the annual American Society of Hematology ...

At ASH 2025, Fulcrum presented promising data on a sickle cell pill and Incyte is pioneering a new way to treat myelofibrosis ...

Incyte's data bolster efforts to develop a new type of drug for myelofibrosis, and suggest it may be a replacement for Jakafi ...

A higher dose of the experimental pill for sickle cell disease showed more promise, Fulcrum said at the American Society of ...

A new report looks at Chinese biotech innovation capturing the attention of pharmaceutical executives and investors worldwide ...

The Advisory Committee on Immunization Practices' (ACIP) meetings used to be a geek’s dream: hours of long, maybe dreary ...

The CDC's ACIP panel voted to recommend delaying the birth dose of the hepatitis B vaccine, ending a policy that has reined ...

At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, ...

John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration ...

WASHINGTON — Federal vaccine advisers, through a freewheeling, and at times combative two-day meeting, recommended a major ...

ACIP has drifted toward inflating speculative risks while downplaying well-established vaccine benefits,” write former CDC ...

A panel that issues advice on U.S. vaccine policy appears prepared to vote to recommend a delay in when most babies begin to ...